Page last updated: 2024-11-07
alpha-methylene glutarate
Description
2-methylenepentanedioic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
2-methylideneglutaric acid : A dicarboxylic acid comprising a glutaric acid core with a methylene group at the 2-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 95155 |
| CHEBI ID | 17207 |
| SCHEMBL ID | 26631 |
| MeSH ID | M0042664 |
Synonyms (30)
| Synonym |
|---|
| 2-methylene-pentanedioic acid |
| CHEBI:17207 |
| 2-methylideneglutaric acid |
| 2-methylidenepentanedioic acid |
| pentanedioic acid, 2-methylene- |
| nsc-21369 |
| nsc21369 |
| alpha-methylene glutarate |
| 3621-79-2 |
| C02930 |
| 2-methyleneglutaric acid |
| FT-0691802 |
| AKOS006295783 |
| 2-methylene glutarate |
| unii-nz83s5jr9d |
| nsc 21369 |
| nz83s5jr9d , |
| SCHEMBL26631 |
| CWNNYYIZGGDCHS-UHFFFAOYSA-N |
| alpha-methyleneglutaric acid |
| LMFA01020394 |
| DTXSID00189768 |
| a-methyleneglutaric acid |
| 2-methylenepentanedioic acid |
| glutaric acid, 2-methylene- |
| .alpha.-methylene glutarate |
| 1-butene-2,4-dicarboxylic acid |
| Q27102261 |
| 2-methylenepentanedioicacid |
| BS-25127 |
Drug Classes (2)
| Class | Description |
|---|
| dicarboxylic acid | Any carboxylic acid containing two carboxy groups. |
| dicarboxylic fatty acid | |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.06
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.06 (24.57) | | Research Supply Index | 2.08 (2.92) | | Research Growth Index | 4.14 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |